Advances in Pharmacoepidemiology and Drug Safety

Hagos L

Publications

• Research Article
  Second-line Anti-Tuberculosis Drugs and Risk of Alopecia: A Retrospective Cohort study
  Author(s): Russom M, Berhe A and Hagos LRussom M, Berhe A and Hagos L
  
  Background  Alopecia is not a well-known adverse effect of second-line anti-tuberculosis drugs. It is however, been frequently reported in Eritrea and 83% of the reports of alopecia associated with second-line anti-TB drugs in the global adverse drug reaction database, as of July 25, 2017, were submitted from Eritrea. It is wondering why this much variation is happening and this study is therefore aimed at quantifying the risk, identifying possible risk factors and elucidating the causal association between alopecia and the second-line anti-TB drugs in Eritrea. Methods This was a retrospective cohort study that included all patients with multi-drug resistant tuberculosis (MDR-TB) in Eritrea enrolled to Merhano MDR-TB referral hospital for treatment between June 2011 and December 2016. Resu.. View More»
  

  Abstract PDF